Comparison of the 1 and 2% pilocarpine mouthwash in a xerostomic population: a randomized clinical trial

Abstract Aims & background Pilocarpine is an accepted treatment for xerostomia, but limited research has been conducted on the oral, topical form. The present study aimed to compare the effects of 1 and 2% pilocarpine mouthwash on xerostomic participants. Methods In this double-blind clinical tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Babak Motamed (Author), Arezoo Alaee (Author), Arash Azizi (Author), Hoda Jahandar (Author), Mohammad Javad Kharazi Fard (Author), Aryan Jafari (Author)
Format: Book
Published: BMC, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_10d3cc9afb06443cbb42fdf06eb97ec8
042 |a dc 
100 1 0 |a Babak Motamed  |e author 
700 1 0 |a Arezoo Alaee  |e author 
700 1 0 |a Arash Azizi  |e author 
700 1 0 |a Hoda Jahandar  |e author 
700 1 0 |a Mohammad Javad Kharazi Fard  |e author 
700 1 0 |a Aryan Jafari  |e author 
245 0 0 |a Comparison of the 1 and 2% pilocarpine mouthwash in a xerostomic population: a randomized clinical trial 
260 |b BMC,   |c 2022-12-01T00:00:00Z. 
500 |a 10.1186/s12903-022-02576-6 
500 |a 1472-6831 
520 |a Abstract Aims & background Pilocarpine is an accepted treatment for xerostomia, but limited research has been conducted on the oral, topical form. The present study aimed to compare the effects of 1 and 2% pilocarpine mouthwash on xerostomic participants. Methods In this double-blind clinical trial study, 48 subjects with xerostomia were randomly divided into three groups to measure the effects of 1 and 2% pilocarpine and placebo mouthwashes on saliva levels. The amount of saliva in the 1st and 14th days was measured at 0, 45, 60, and 75 mins, while participants used their mouthwash three times a day for 14 days. On the 1st and 14th days, they filled out the information forms on xerostomia and the medicine's side effects before and after the intervention. Results On the 1st day, the mean salivary flow at 45, 60, and 75 mins in the 2 and 1% pilocarpine mouthwash were significantly higher than in the placebo mouthwash group (p < 0.05). On the 14th day, the mean salivary flow time at 45 mins in the 2% pilocarpine mouthwash group was significantly higher than in the placebo mouthwash group (p = 0.007). Furthermore, the mean salivary flow at 60 and 75 mins in the 2% (p < 0.001) and 1% pilocarpine mouthwash (p = 0.028) was significantly higher than in the placebo group. Moreover, the salivary flow in the 2% pilocarpine mouthwash group was significantly higher than the 1% pilocarpine mouthwash (p < 0.05) during these two times. No side effects were observed in any of the subjects. Conclusions The study showed that 5 ml of 2 and 1% pilocarpine mouthwash for 2 weeks increased salivary flow in xerostomic participants compared to placebo without any side effects. 
546 |a EN 
690 |a Pilocarpine 
690 |a Xerostomia  
690 |a Dry mouth 
690 |a Oral health 
690 |a Saliva measurement methods 
690 |a Muscarinic agonists 
690 |a Dentistry 
690 |a RK1-715 
655 7 |a article  |2 local 
786 0 |n BMC Oral Health, Vol 22, Iss 1, Pp 1-8 (2022) 
787 0 |n https://doi.org/10.1186/s12903-022-02576-6 
787 0 |n https://doaj.org/toc/1472-6831 
856 4 1 |u https://doaj.org/article/10d3cc9afb06443cbb42fdf06eb97ec8  |z Connect to this object online.